Galapagos | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
argenx SE USD 285.94M 8.24M 2024-12
AstraZeneca USD 3.59B 1.96B 2025-03
Biogen USD 677.3M 99.6M 2024-12
Genmab DKK 1.25B 384M 2024-12
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
GRIFOLS EUR 269.48M 49.95M 2024-12
Hikma Pharmaceutical USD 280M 4M 2024-06
Incyte USD 325.69M 1.02M 2025-03
Merck EUR 1.05B 361M 2024-12
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Novartis USD 3.5B 368M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03
UCB EUR 533M 434M 2024-06
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



Galapagos Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.